

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.95915317 |
| 2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.95915317 |
| 3 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.68304814 |
| 4 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.49667927 |
| 5 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.45854780 |
| 6 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.45854780 |
| 7 | modulation by symbiont of host immune response (GO:0052553) | 4.45854780 |
| 8 | positive regulation by symbiont of host defense response (GO:0052509) | 4.45854780 |
| 9 | modulation by symbiont of host defense response (GO:0052031) | 4.45854780 |
| 10 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.45854780 |
| 11 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.42438624 |
| 12 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.15501990 |
| 13 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.04623709 |
| 14 | negative regulation of phagocytosis (GO:0050765) | 3.89908366 |
| 15 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.84054875 |
| 16 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.74798884 |
| 17 | immunoglobulin mediated immune response (GO:0016064) | 3.74132603 |
| 18 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.61272441 |
| 19 | * Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.58762725 |
| 20 | ATP synthesis coupled proton transport (GO:0015986) | 3.53011884 |
| 21 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.53011884 |
| 22 | pentose-phosphate shunt (GO:0006098) | 3.52325203 |
| 23 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.51724800 |
| 24 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.47044060 |
| 25 | positive regulation of B cell differentiation (GO:0045579) | 3.46448083 |
| 26 | positive thymic T cell selection (GO:0045059) | 3.34319513 |
| 27 | regulation of gamma-delta T cell activation (GO:0046643) | 3.34101593 |
| 28 | positive regulation of interferon-alpha production (GO:0032727) | 3.31287539 |
| 29 | detection of other organism (GO:0098543) | 3.28552014 |
| 30 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.27305012 |
| 31 | negative regulation of cell killing (GO:0031342) | 3.27305012 |
| 32 | neutrophil activation (GO:0042119) | 3.26784637 |
| 33 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.25147832 |
| 34 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.22530342 |
| 35 | protein targeting to ER (GO:0045047) | 3.20922333 |
| 36 | regulation of interferon-alpha production (GO:0032647) | 3.19218478 |
| 37 | T cell apoptotic process (GO:0070231) | 3.18620439 |
| 38 | detection of bacterium (GO:0016045) | 3.18488825 |
| 39 | B cell receptor signaling pathway (GO:0050853) | 3.17795318 |
| 40 | positive regulation of mast cell activation (GO:0033005) | 3.17374202 |
| 41 | cotranslational protein targeting to membrane (GO:0006613) | 3.16738215 |
| 42 | polyketide metabolic process (GO:0030638) | 3.16548309 |
| 43 | doxorubicin metabolic process (GO:0044598) | 3.16548309 |
| 44 | daunorubicin metabolic process (GO:0044597) | 3.16548309 |
| 45 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.15296501 |
| 46 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.13862644 |
| 47 | granulocyte activation (GO:0036230) | 3.13477385 |
| 48 | leukocyte aggregation (GO:0070486) | 3.13172788 |
| 49 | macrophage activation involved in immune response (GO:0002281) | 3.10733402 |
| 50 | B cell mediated immunity (GO:0019724) | 3.09222596 |
| 51 | negative regulation of interleukin-12 production (GO:0032695) | 3.08836847 |
| 52 | response to interferon-beta (GO:0035456) | 3.08706314 |
| 53 | positive regulation of mast cell degranulation (GO:0043306) | 3.07280044 |
| 54 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.07280044 |
| 55 | protein localization to endoplasmic reticulum (GO:0070972) | 3.07237812 |
| 56 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.06282325 |
| 57 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.04032246 |
| 58 | NADPH regeneration (GO:0006740) | 3.03010586 |
| 59 | positive regulation of lamellipodium assembly (GO:0010592) | 3.02779468 |
| 60 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.01244669 |
| 61 | regulation of mast cell degranulation (GO:0043304) | 3.01113526 |
| 62 | regulation of T cell tolerance induction (GO:0002664) | 3.00484112 |
| 63 | regulation of protein heterodimerization activity (GO:0043497) | 2.97991344 |
| 64 | ribosomal small subunit biogenesis (GO:0042274) | 2.96601124 |
| 65 | response to host immune response (GO:0052572) | 2.95350000 |
| 66 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.95350000 |
| 67 | detection of molecule of bacterial origin (GO:0032490) | 2.94007756 |
| 68 | regulation of B cell differentiation (GO:0045577) | 2.92833589 |
| 69 | cellular extravasation (GO:0045123) | 2.91979643 |
| 70 | regulation of tolerance induction (GO:0002643) | 2.91619519 |
| 71 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.88485666 |
| 72 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.86586719 |
| 73 | response to host (GO:0075136) | 2.86586719 |
| 74 | response to host defenses (GO:0052200) | 2.86586719 |
| 75 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.86420552 |
| 76 | response to peptidoglycan (GO:0032494) | 2.86242124 |
| 77 | regulation of mast cell activation (GO:0033003) | 2.84630289 |
| 78 | microglial cell activation (GO:0001774) | 2.84486391 |
| 79 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.84397033 |
| 80 | tolerance induction (GO:0002507) | 2.83642692 |
| 81 | viral transcription (GO:0019083) | 2.83449464 |
| 82 | pinocytosis (GO:0006907) | 2.83408637 |
| 83 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.81254352 |
| 84 | positive regulation of histone deacetylation (GO:0031065) | 2.79979728 |
| 85 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.79228517 |
| 86 | positive regulation of antigen processing and presentation (GO:0002579) | 2.78674995 |
| 87 | detection of external biotic stimulus (GO:0098581) | 2.75916029 |
| 88 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.75905198 |
| 89 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.75388938 |
| 90 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.74759175 |
| 91 | neutrophil activation involved in immune response (GO:0002283) | 2.74174843 |
| 92 | leukocyte degranulation (GO:0043299) | 2.73557826 |
| 93 | respiratory burst (GO:0045730) | 2.73375599 |
| 94 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.72520338 |
| 95 | ribosomal small subunit assembly (GO:0000028) | 2.72080632 |
| 96 | viral life cycle (GO:0019058) | 2.70790492 |
| 97 | hepatocyte apoptotic process (GO:0097284) | 2.70761989 |
| 98 | lymphocyte apoptotic process (GO:0070227) | 2.70034976 |
| 99 | thymic T cell selection (GO:0045061) | 2.69634562 |
| 100 | negative thymic T cell selection (GO:0045060) | 2.68972393 |
| 101 | regulation of antigen processing and presentation (GO:0002577) | 2.68508834 |
| 102 | mast cell activation (GO:0045576) | 2.67730251 |
| 103 | translational termination (GO:0006415) | 2.66351406 |
| 104 | response to type I interferon (GO:0034340) | 2.65723571 |
| 105 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.65573701 |
| 106 | leukocyte cell-cell adhesion (GO:0007159) | 2.64022561 |
| 107 | positive regulation of lamellipodium organization (GO:1902745) | 2.63902765 |
| 108 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.63882871 |
| 109 | regulation of response to interferon-gamma (GO:0060330) | 2.63754306 |
| 110 | cellular response to interferon-gamma (GO:0071346) | 2.63385783 |
| 111 | respiratory electron transport chain (GO:0022904) | 2.63262707 |
| 112 | type I interferon signaling pathway (GO:0060337) | 2.62849274 |
| 113 | cellular response to type I interferon (GO:0071357) | 2.62849274 |
| 114 | response to fungus (GO:0009620) | 2.62390044 |
| 115 | myeloid dendritic cell differentiation (GO:0043011) | 2.62245890 |
| 116 | negative T cell selection (GO:0043383) | 2.61690479 |
| 117 | barbed-end actin filament capping (GO:0051016) | 2.60575900 |
| 118 | morphogenesis of an endothelium (GO:0003159) | 2.59599342 |
| 119 | endothelial tube morphogenesis (GO:0061154) | 2.59599342 |
| 120 | defense response to protozoan (GO:0042832) | 2.59547651 |
| 121 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.58434995 |
| 122 | protein neddylation (GO:0045116) | 2.58309635 |
| 123 | negative regulation of granulocyte differentiation (GO:0030853) | 2.57061785 |
| 124 | NIK/NF-kappaB signaling (GO:0038061) | 2.56426379 |
| 125 | T cell costimulation (GO:0031295) | 2.56386563 |
| 126 | * actin nucleation (GO:0045010) | 2.56110250 |
| 127 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.55886235 |
| 128 | electron transport chain (GO:0022900) | 2.55845167 |
| 129 | myeloid dendritic cell activation (GO:0001773) | 2.55269903 |
| 130 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.55192152 |
| 131 | T cell migration (GO:0072678) | 2.54972841 |
| 132 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.53945397 |
| 133 | lymphocyte costimulation (GO:0031294) | 2.53298391 |
| 134 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.52797228 |
| 135 | response to interferon-gamma (GO:0034341) | 2.51446644 |
| 136 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.50919994 |
| 137 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.50154594 |
| 138 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.50147017 |
| 139 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.50080045 |
| 140 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.49865473 |
| 141 | response to protozoan (GO:0001562) | 2.49340363 |
| 142 | response to muramyl dipeptide (GO:0032495) | 2.48836309 |
| 143 | cytidine deamination (GO:0009972) | 2.48431259 |
| 144 | cytidine catabolic process (GO:0006216) | 2.48431259 |
| 145 | defense response to fungus (GO:0050832) | 2.44560229 |
| 146 | glucose catabolic process (GO:0006007) | 2.43386271 |
| 147 | myeloid cell activation involved in immune response (GO:0002275) | 2.43170694 |
| 148 | translational elongation (GO:0006414) | 2.41193792 |
| 149 | low-density lipoprotein particle clearance (GO:0034383) | 2.40674808 |
| 150 | lymphocyte homeostasis (GO:0002260) | 2.40624288 |
| 151 | mannose metabolic process (GO:0006013) | 2.40333955 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.69474042 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.53824677 |
| 3 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.50498442 |
| 4 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.34625706 |
| 5 | MYC_22102868_ChIP-Seq_BL_Human | 3.30627677 |
| 6 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.01277811 |
| 7 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.93974031 |
| 8 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.93809107 |
| 9 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.89919166 |
| 10 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.89365678 |
| 11 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.81422123 |
| 12 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.68058761 |
| 13 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.66726313 |
| 14 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.53358839 |
| 15 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.46741220 |
| 16 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.44979310 |
| 17 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.44549123 |
| 18 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.39415974 |
| 19 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.37036862 |
| 20 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.35896047 |
| 21 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.34390231 |
| 22 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.32192101 |
| 23 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.30059568 |
| 24 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.28110819 |
| 25 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.21391749 |
| 26 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.17625229 |
| 27 | MAF_26560356_Chip-Seq_TH1_Human | 2.17548100 |
| 28 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.08445812 |
| 29 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.07268140 |
| 30 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.06744713 |
| 31 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.00817729 |
| 32 | UTX_26944678_Chip-Seq_JUKART_Human | 1.96014716 |
| 33 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.95742788 |
| 34 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.95033754 |
| 35 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.94270522 |
| 36 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.93998368 |
| 37 | MYB_26560356_Chip-Seq_TH2_Human | 1.93841606 |
| 38 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.93122907 |
| 39 | * VDR_23849224_ChIP-Seq_CD4+_Human | 1.89172196 |
| 40 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.88900802 |
| 41 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.86826654 |
| 42 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.85094455 |
| 43 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.80341745 |
| 44 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.79922810 |
| 45 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.79817941 |
| 46 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.79704784 |
| 47 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.75328167 |
| 48 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.65199400 |
| 49 | MYB_26560356_Chip-Seq_TH1_Human | 1.64783005 |
| 50 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.62638780 |
| 51 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.62089187 |
| 52 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.60859203 |
| 53 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.60666719 |
| 54 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.59158113 |
| 55 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.59134258 |
| 56 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.58337188 |
| 57 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.58073115 |
| 58 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.57258554 |
| 59 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.56850760 |
| 60 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.55975955 |
| 61 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.55533098 |
| 62 | MAF_26560356_Chip-Seq_TH2_Human | 1.47562878 |
| 63 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.47106228 |
| 64 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.45063977 |
| 65 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.44289296 |
| 66 | * ELK1_19687146_ChIP-ChIP_HELA_Human | 1.42224862 |
| 67 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.41063421 |
| 68 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.40435501 |
| 69 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.40386697 |
| 70 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.39092077 |
| 71 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.38858075 |
| 72 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.38422509 |
| 73 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.37974536 |
| 74 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.34389948 |
| 75 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.32733944 |
| 76 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.31761193 |
| 77 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.30362150 |
| 78 | GATA3_26560356_Chip-Seq_TH2_Human | 1.29602033 |
| 79 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.29280296 |
| 80 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.27944628 |
| 81 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.26977809 |
| 82 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.26146831 |
| 83 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.22743174 |
| 84 | GATA1_22025678_ChIP-Seq_K562_Human | 1.22682405 |
| 85 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.22015794 |
| 86 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.18449091 |
| 87 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.17869692 |
| 88 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.14325801 |
| 89 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.13839453 |
| 90 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.13324800 |
| 91 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.13173218 |
| 92 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.13054285 |
| 93 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.12369703 |
| 94 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.11912058 |
| 95 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.11775445 |
| 96 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.11767843 |
| 97 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.10195871 |
| 98 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.09839366 |
| 99 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.09770330 |
| 100 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.09693712 |
| 101 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.09501497 |
| 102 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.09086864 |
| 103 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.08604381 |
| 104 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.07499474 |
| 105 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.06658055 |
| 106 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.04053013 |
| 107 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.03879010 |
| 108 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.03066572 |
| 109 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.02653341 |
| 110 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.02565754 |
| 111 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.02180118 |
| 112 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.02173383 |
| 113 | ATF3_27146783_Chip-Seq_COLON_Human | 1.02089508 |
| 114 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.01516250 |
| 115 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.00070947 |
| 116 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.99145820 |
| 117 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 0.99121518 |
| 118 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.98221096 |
| 119 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.97919668 |
| 120 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.95216407 |
| 121 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.94954058 |
| 122 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.94850131 |
| 123 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.94400116 |
| 124 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.93799296 |
| 125 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.93104332 |
| 126 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.92909323 |
| 127 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.92859923 |
| 128 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.92223063 |
| 129 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.91393255 |
| 130 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.91173208 |
| 131 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.90569154 |
| 132 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.89857496 |
| 133 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.89844826 |
| 134 | GATA1_19941826_ChIP-Seq_K562_Human | 0.89750000 |
| 135 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.88708277 |
| 136 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.87771116 |
| 137 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.87708254 |
| 138 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.87578414 |
| 139 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.87171860 |
| 140 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.86044592 |
| 141 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.85437717 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003303_peritoneal_inflammation | 3.77168284 |
| 2 | MP0001835_abnormal_antigen_presentation | 3.33498960 |
| 3 | MP0003300_gastrointestinal_ulcer | 3.03034918 |
| 4 | MP0003436_decreased_susceptibility_to | 2.93371432 |
| 5 | MP0003806_abnormal_nucleotide_metabolis | 2.83355717 |
| 6 | MP0000685_abnormal_immune_system | 2.76268251 |
| 7 | MP0001800_abnormal_humoral_immune | 2.56868776 |
| 8 | MP0005387_immune_system_phenotype | 2.45401425 |
| 9 | MP0001790_abnormal_immune_system | 2.45401425 |
| 10 | MP0009785_altered_susceptibility_to | 2.43210691 |
| 11 | MP0005000_abnormal_immune_tolerance | 2.38524875 |
| 12 | MP0002452_abnormal_antigen_presenting | 2.35309124 |
| 13 | MP0005058_abnormal_lysosome_morphology | 2.32115500 |
| 14 | MP0002419_abnormal_innate_immunity | 2.27561850 |
| 15 | MP0005671_abnormal_response_to | 2.27389427 |
| 16 | MP0005025_abnormal_response_to | 2.23706174 |
| 17 | MP0005464_abnormal_platelet_physiology | 2.19199435 |
| 18 | MP0002723_abnormal_immune_serum | 2.15659479 |
| 19 | MP0002420_abnormal_adaptive_immunity | 2.15508061 |
| 20 | MP0001819_abnormal_immune_cell | 2.14349455 |
| 21 | MP0004510_myositis | 2.03322897 |
| 22 | MP0006082_CNS_inflammation | 1.98425482 |
| 23 | MP0002398_abnormal_bone_marrow | 1.98155333 |
| 24 | MP0009840_abnormal_foam_cell | 1.94837681 |
| 25 | MP0004947_skin_inflammation | 1.92559546 |
| 26 | MP0009333_abnormal_splenocyte_physiolog | 1.90132751 |
| 27 | MP0002396_abnormal_hematopoietic_system | 1.89605441 |
| 28 | MP0003191_abnormal_cellular_cholesterol | 1.89144990 |
| 29 | MP0002148_abnormal_hypersensitivity_rea | 1.86581262 |
| 30 | MP0010352_gastrointestinal_tract_polyps | 1.85318965 |
| 31 | MP0002405_respiratory_system_inflammati | 1.81450609 |
| 32 | MP0000716_abnormal_immune_system | 1.79211713 |
| 33 | MP0010155_abnormal_intestine_physiology | 1.76867319 |
| 34 | MP0003705_abnormal_hypodermis_morpholog | 1.76489473 |
| 35 | MP0002166_altered_tumor_susceptibility | 1.76348433 |
| 36 | MP0003566_abnormal_cell_adhesion | 1.75935740 |
| 37 | MP0003763_abnormal_thymus_physiology | 1.75916023 |
| 38 | MP0009278_abnormal_bone_marrow | 1.72518485 |
| 39 | MP0003172_abnormal_lysosome_physiology | 1.72474277 |
| 40 | MP0000689_abnormal_spleen_morphology | 1.71900555 |
| 41 | MP0005397_hematopoietic_system_phenotyp | 1.69660857 |
| 42 | MP0001545_abnormal_hematopoietic_system | 1.69660857 |
| 43 | MP0001845_abnormal_inflammatory_respons | 1.69190057 |
| 44 | MP0002722_abnormal_immune_system | 1.67965472 |
| 45 | MP0001873_stomach_inflammation | 1.67811862 |
| 46 | MP0001533_abnormal_skeleton_physiology | 1.64422546 |
| 47 | MP0000465_gastrointestinal_hemorrhage | 1.61200820 |
| 48 | MP0002429_abnormal_blood_cell | 1.60185093 |
| 49 | MP0003724_increased_susceptibility_to | 1.58747565 |
| 50 | MP0001853_heart_inflammation | 1.58685899 |
| 51 | MP0002132_abnormal_respiratory_system | 1.58414757 |
| 52 | MP0004808_abnormal_hematopoietic_stem | 1.53649630 |
| 53 | MP0000490_abnormal_crypts_of | 1.52132351 |
| 54 | MP0010307_abnormal_tumor_latency | 1.51770443 |
| 55 | MP0008260_abnormal_autophagy | 1.51706096 |
| 56 | MP0000858_altered_metastatic_potential | 1.46861998 |
| 57 | MP0009379_abnormal_foot_pigmentation | 1.37284826 |
| 58 | MP0002006_tumorigenesis | 1.36923755 |
| 59 | MP0003448_altered_tumor_morphology | 1.36323911 |
| 60 | MP0003866_abnormal_defecation | 1.35462186 |
| 61 | MP0000343_altered_response_to | 1.35298990 |
| 62 | MP0002277_abnormal_respiratory_mucosa | 1.34173146 |
| 63 | MP0008469_abnormal_protein_level | 1.32763887 |
| 64 | MP0005076_abnormal_cell_differentiation | 1.30990859 |
| 65 | MP0005310_abnormal_salivary_gland | 1.30666233 |
| 66 | MP0000703_abnormal_thymus_morphology | 1.29215546 |
| 67 | MP0006054_spinal_hemorrhage | 1.25832329 |
| 68 | MP0003186_abnormal_redox_activity | 1.22848616 |
| 69 | MP0005084_abnormal_gallbladder_morpholo | 1.22063500 |
| 70 | MP0003075_altered_response_to | 1.21808580 |
| 71 | MP0003656_abnormal_erythrocyte_physiolo | 1.20962919 |
| 72 | MP0010234_abnormal_vibrissa_follicle | 1.15434013 |
| 73 | MP0004883_abnormal_blood_vessel | 1.15135039 |
| 74 | MP0003693_abnormal_embryo_hatching | 1.11429884 |
| 75 | MP0008004_abnormal_stomach_pH | 1.10911970 |
| 76 | MP0002877_abnormal_melanocyte_morpholog | 1.08232395 |
| 77 | MP0005023_abnormal_wound_healing | 1.07850443 |
| 78 | MP0005075_abnormal_melanosome_morpholog | 1.06563153 |
| 79 | MP0002933_joint_inflammation | 1.06267236 |
| 80 | MP0006036_abnormal_mitochondrial_physio | 0.98014440 |
| 81 | MP0005164_abnormal_response_to | 0.97786998 |
| 82 | MP0002019_abnormal_tumor_incidence | 0.97500542 |
| 83 | MP0002998_abnormal_bone_remodeling | 0.97111372 |
| 84 | MP0000604_amyloidosis | 0.96912440 |
| 85 | MP0003183_abnormal_peptide_metabolism | 0.94313949 |
| 86 | MP0005166_decreased_susceptibility_to | 0.94009210 |
| 87 | MP0009764_decreased_sensitivity_to | 0.93881940 |
| 88 | MP0003453_abnormal_keratinocyte_physiol | 0.91544444 |
| 89 | MP0000609_abnormal_liver_physiology | 0.90219022 |
| 90 | MP0001851_eye_inflammation | 0.89760077 |
| 91 | MP0001663_abnormal_digestive_system | 0.89438082 |
| 92 | MP0001542_abnormal_bone_strength | 0.84255879 |
| 93 | MP0005167_abnormal_blood-brain_barrier | 0.82921066 |
| 94 | MP0002136_abnormal_kidney_physiology | 0.79094693 |
| 95 | MP0005451_abnormal_body_composition | 0.78702928 |
| 96 | MP0002138_abnormal_hepatobiliary_system | 0.78622688 |
| 97 | MP0000249_abnormal_blood_vessel | 0.78554568 |
| 98 | MP0003045_fibrosis | 0.77631300 |
| 99 | MP0005083_abnormal_biliary_tract | 0.77163344 |
| 100 | MP0009765_abnormal_xenobiotic_induced | 0.74558498 |
| 101 | MP0005408_hypopigmentation | 0.74068076 |
| 102 | MP0002139_abnormal_hepatobiliary_system | 0.72737413 |
| 103 | MP0005165_increased_susceptibility_to | 0.69629054 |
| 104 | MP0003091_abnormal_cell_migration | 0.69366323 |
| 105 | MP0009763_increased_sensitivity_to | 0.69212632 |
| 106 | MP0005174_abnormal_tail_pigmentation | 0.68855702 |
| 107 | MP0003795_abnormal_bone_structure | 0.68547896 |
| 108 | MP0000598_abnormal_liver_morphology | 0.68280187 |
| 109 | MP0003077_abnormal_cell_cycle | 0.67497075 |
| 110 | MP0003828_pulmonary_edema | 0.67257533 |
| 111 | MP0000477_abnormal_intestine_morphology | 0.65668980 |
| 112 | MP0003252_abnormal_bile_duct | 0.64182265 |
| 113 | MP0005390_skeleton_phenotype | 0.63290892 |
| 114 | MP0005319_abnormal_enzyme/_coenzyme | 0.63273863 |
| 115 | MP0009643_abnormal_urine_homeostasis | 0.62527982 |
| 116 | MP0008873_increased_physiological_sensi | 0.62492744 |
| 117 | MP0001958_emphysema | 0.62136449 |
| 118 | MP0001764_abnormal_homeostasis | 0.61993521 |
| 119 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.61851698 |
| 120 | MP0008961_abnormal_basal_metabolism | 0.60543719 |
| 121 | MP0002163_abnormal_gland_morphology | 0.59832570 |
| 122 | MP0002693_abnormal_pancreas_physiology | 0.59684203 |
| 123 | MP0008438_abnormal_cutaneous_collagen | 0.59677640 |
| 124 | MP0003786_premature_aging | 0.57919591 |
| 125 | MP0000372_irregular_coat_pigmentation | 0.57382681 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Chronic otitis media (HP:0000389) | 4.51506532 |
| 2 | Recurrent abscess formation (HP:0002722) | 4.37230743 |
| 3 | Eczematoid dermatitis (HP:0000976) | 4.33714033 |
| 4 | Recurrent bacterial skin infections (HP:0005406) | 3.80761723 |
| 5 | Myositis (HP:0100614) | 3.71733998 |
| 6 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.49467868 |
| 7 | Cellulitis (HP:0100658) | 3.32334376 |
| 8 | Increased cerebral lipofuscin (HP:0011813) | 3.29473328 |
| 9 | IgM deficiency (HP:0002850) | 3.16839343 |
| 10 | Recurrent fungal infections (HP:0002841) | 3.16104687 |
| 11 | Recurrent viral infections (HP:0004429) | 3.15427846 |
| 12 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.15401571 |
| 13 | Interstitial pulmonary disease (HP:0006530) | 3.15294010 |
| 14 | Increased IgM level (HP:0003496) | 3.10414922 |
| 15 | Abnormality of the nasal mucosa (HP:0000433) | 3.06964395 |
| 16 | Thrombocytosis (HP:0001894) | 3.06358479 |
| 17 | Nasal polyposis (HP:0100582) | 3.05958450 |
| 18 | Autoimmune thrombocytopenia (HP:0001973) | 3.01883300 |
| 19 | Systemic lupus erythematosus (HP:0002725) | 2.99430359 |
| 20 | Abnormality of macrophages (HP:0004311) | 2.98341303 |
| 21 | Mitochondrial inheritance (HP:0001427) | 2.96260008 |
| 22 | Encephalitis (HP:0002383) | 2.94803146 |
| 23 | Vacuolated lymphocytes (HP:0001922) | 2.86623678 |
| 24 | Recurrent bronchitis (HP:0002837) | 2.85978824 |
| 25 | Increased density of long bones (HP:0006392) | 2.85928709 |
| 26 | Orchitis (HP:0100796) | 2.85645617 |
| 27 | Dysostosis multiplex (HP:0000943) | 2.84511830 |
| 28 | Pustule (HP:0200039) | 2.83404717 |
| 29 | Acute necrotizing encephalopathy (HP:0006965) | 2.82772404 |
| 30 | Aplastic anemia (HP:0001915) | 2.81657799 |
| 31 | Mediastinal lymphadenopathy (HP:0100721) | 2.81398078 |
| 32 | Petechiae (HP:0000967) | 2.79626333 |
| 33 | Gastrointestinal inflammation (HP:0004386) | 2.73637223 |
| 34 | Inflammation of the large intestine (HP:0002037) | 2.70902087 |
| 35 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.69870651 |
| 36 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.69870651 |
| 37 | 3-Methylglutaconic aciduria (HP:0003535) | 2.69063690 |
| 38 | Hepatocellular necrosis (HP:0001404) | 2.69035663 |
| 39 | Spontaneous hematomas (HP:0007420) | 2.68522336 |
| 40 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.68469324 |
| 41 | Meningitis (HP:0001287) | 2.68081083 |
| 42 | Colitis (HP:0002583) | 2.66792304 |
| 43 | Papilloma (HP:0012740) | 2.64399950 |
| 44 | Verrucae (HP:0200043) | 2.64399950 |
| 45 | Impaired platelet aggregation (HP:0003540) | 2.63064316 |
| 46 | Abnormal platelet function (HP:0011869) | 2.63064316 |
| 47 | Chronic obstructive pulmonary disease (HP:0006510) | 2.62747893 |
| 48 | Obstructive lung disease (HP:0006536) | 2.62747893 |
| 49 | Urticaria (HP:0001025) | 2.62570427 |
| 50 | Mucopolysacchariduria (HP:0008155) | 2.59126773 |
| 51 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.59126773 |
| 52 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.58739941 |
| 53 | Renal Fanconi syndrome (HP:0001994) | 2.57115347 |
| 54 | Exertional dyspnea (HP:0002875) | 2.56687649 |
| 55 | Arterial thrombosis (HP:0004420) | 2.55801768 |
| 56 | Hematochezia (HP:0002573) | 2.52955833 |
| 57 | Increased CSF lactate (HP:0002490) | 2.52048276 |
| 58 | Vasculitis (HP:0002633) | 2.49874815 |
| 59 | Hepatosplenomegaly (HP:0001433) | 2.48805645 |
| 60 | Increased hepatocellular lipid droplets (HP:0006565) | 2.47742932 |
| 61 | Recurrent skin infections (HP:0001581) | 2.46004826 |
| 62 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.45832127 |
| 63 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.44142709 |
| 64 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.41828133 |
| 65 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.41828133 |
| 66 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.41828133 |
| 67 | Autoimmune hemolytic anemia (HP:0001890) | 2.40455599 |
| 68 | Progressive macrocephaly (HP:0004481) | 2.38221128 |
| 69 | Hepatic necrosis (HP:0002605) | 2.37263010 |
| 70 | Amyloidosis (HP:0011034) | 2.36324806 |
| 71 | Increased IgE level (HP:0003212) | 2.35668785 |
| 72 | Chronic diarrhea (HP:0002028) | 2.34887515 |
| 73 | Increased intramyocellular lipid droplets (HP:0012240) | 2.34766240 |
| 74 | Acute encephalopathy (HP:0006846) | 2.33997898 |
| 75 | Hypergammaglobulinemia (HP:0010702) | 2.29998595 |
| 76 | Lipid accumulation in hepatocytes (HP:0006561) | 2.29432363 |
| 77 | Skin rash (HP:0000988) | 2.28885859 |
| 78 | Osteomyelitis (HP:0002754) | 2.27700078 |
| 79 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.26753193 |
| 80 | Prolonged bleeding time (HP:0003010) | 2.26681285 |
| 81 | Respiratory difficulties (HP:0002880) | 2.26380426 |
| 82 | Abnormality of T cells (HP:0002843) | 2.24979605 |
| 83 | Lymphopenia (HP:0001888) | 2.24890538 |
| 84 | Retrobulbar optic neuritis (HP:0100654) | 2.24222939 |
| 85 | Optic neuritis (HP:0100653) | 2.24222939 |
| 86 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.23389477 |
| 87 | Abnormality of the prostate (HP:0008775) | 2.22914302 |
| 88 | Abnormality of B cell number (HP:0010975) | 2.22904611 |
| 89 | Keratoconjunctivitis sicca (HP:0001097) | 2.22174097 |
| 90 | Abnormality of T cell physiology (HP:0011840) | 2.20859418 |
| 91 | Chest pain (HP:0100749) | 2.20762329 |
| 92 | Granulocytopenia (HP:0001913) | 2.18789637 |
| 93 | Bilateral sensorineural hearing impairment (HP:0008619) | 2.17767234 |
| 94 | Chronic sinusitis (HP:0011109) | 2.17485528 |
| 95 | Alopecia of scalp (HP:0002293) | 2.17223530 |
| 96 | Agammaglobulinemia (HP:0004432) | 2.15821093 |
| 97 | Abnormal platelet volume (HP:0011876) | 2.15528055 |
| 98 | Disinhibition (HP:0000734) | 2.15339025 |
| 99 | IgG deficiency (HP:0004315) | 2.14865453 |
| 100 | Increased serum ferritin (HP:0003281) | 2.14080957 |
| 101 | Gangrene (HP:0100758) | 2.13801136 |
| 102 | Anorexia (HP:0002039) | 2.13483733 |
| 103 | Fatigue (HP:0012378) | 2.11436569 |
| 104 | Progressive neurologic deterioration (HP:0002344) | 2.11388624 |
| 105 | Periodontitis (HP:0000704) | 2.10545140 |
| 106 | B lymphocytopenia (HP:0010976) | 2.08667286 |
| 107 | Epistaxis (HP:0000421) | 2.08413359 |
| 108 | Keratoconjunctivitis (HP:0001096) | 2.07928760 |
| 109 | Increased muscle lipid content (HP:0009058) | 2.07758257 |
| 110 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.07322596 |
| 111 | Skin ulcer (HP:0200042) | 2.06616229 |
| 112 | T lymphocytopenia (HP:0005403) | 2.05923485 |
| 113 | Abnormality of T cell number (HP:0011839) | 2.03147996 |
| 114 | Cheilitis (HP:0100825) | 2.03144520 |
| 115 | Purpura (HP:0000979) | 2.02363208 |
| 116 | Abnormality of glycolipid metabolism (HP:0010969) | 2.01933973 |
| 117 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.01933973 |
| 118 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.01933973 |
| 119 | Loss of speech (HP:0002371) | 2.01061387 |
| 120 | Recurrent cutaneous fungal infections (HP:0011370) | 2.00555779 |
| 121 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.00555779 |
| 122 | Gingivitis (HP:0000230) | 2.00206716 |
| 123 | Panhypogammaglobulinemia (HP:0003139) | 1.99049546 |
| 124 | Gastrointestinal stroma tumor (HP:0100723) | 1.98997055 |
| 125 | Cerebral aneurysm (HP:0004944) | 1.98287132 |
| 126 | Pulmonary infiltrates (HP:0002113) | 1.95381857 |
| 127 | Polycythemia (HP:0001901) | 1.93592302 |
| 128 | Abnormality of the pleura (HP:0002103) | 1.93089045 |
| 129 | Severe combined immunodeficiency (HP:0004430) | 1.92961136 |
| 130 | Abnormality of iron homeostasis (HP:0011031) | 1.92382547 |
| 131 | Macrocytic anemia (HP:0001972) | 1.91411217 |
| 132 | Myocardial infarction (HP:0001658) | 1.91069049 |
| 133 | Emphysema (HP:0002097) | 1.90994586 |
| 134 | Gingival bleeding (HP:0000225) | 1.90850917 |
| 135 | Stomatitis (HP:0010280) | 1.90092115 |
| 136 | Cutaneous melanoma (HP:0012056) | 1.86650720 |
| 137 | Hemoptysis (HP:0002105) | 1.85662511 |
| 138 | Leukocytosis (HP:0001974) | 1.85051484 |
| 139 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.84443773 |
| 140 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.83189894 |
| 141 | Osteolytic defects of the hand bones (HP:0009699) | 1.83189894 |
| 142 | Thoracic kyphosis (HP:0002942) | 1.81986205 |
| 143 | Gastrointestinal infarctions (HP:0005244) | 1.79909466 |
| 144 | Increased mean platelet volume (HP:0011877) | 1.78526990 |
| 145 | Eosinophilia (HP:0001880) | 1.77795049 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.01532688 |
| 2 | TRIB3 | 3.85693115 |
| 3 | PKN2 | 3.33009535 |
| 4 | ERN1 | 3.14523819 |
| 5 | EEF2K | 3.13046844 |
| 6 | LRRK2 | 2.30583584 |
| 7 | BMPR2 | 2.26518594 |
| 8 | TYK2 | 2.20474660 |
| 9 | TBK1 | 2.17077426 |
| 10 | BLK | 2.16288306 |
| 11 | MST4 | 2.09699809 |
| 12 | SCYL2 | 1.98759600 |
| 13 | VRK2 | 1.98242239 |
| 14 | KIT | 1.98148944 |
| 15 | ZAP70 | 1.90677639 |
| 16 | STK10 | 1.88477447 |
| 17 | MAP3K10 | 1.87985964 |
| 18 | GRK6 | 1.86569631 |
| 19 | SIK2 | 1.79265945 |
| 20 | PAK4 | 1.72631178 |
| 21 | NME2 | 1.71721493 |
| 22 | JAK3 | 1.59777076 |
| 23 | BTK | 1.54567738 |
| 24 | TESK2 | 1.53621699 |
| 25 | STK16 | 1.46098919 |
| 26 | TXK | 1.45371473 |
| 27 | SYK | 1.44130879 |
| 28 | SIK1 | 1.42555833 |
| 29 | CSF1R | 1.42490392 |
| 30 | TGFBR2 | 1.39948289 |
| 31 | TTN | 1.33797035 |
| 32 | KDR | 1.33331854 |
| 33 | MAP2K3 | 1.30187622 |
| 34 | JAK1 | 1.29248179 |
| 35 | PTK6 | 1.27530764 |
| 36 | FES | 1.22731741 |
| 37 | GRK7 | 1.21431987 |
| 38 | RPS6KA4 | 1.21396147 |
| 39 | PIM2 | 1.20566660 |
| 40 | CDK19 | 1.19459415 |
| 41 | CSK | 1.18410036 |
| 42 | EPHB1 | 1.17603909 |
| 43 | IKBKE | 1.16151559 |
| 44 | ITK | 1.16140295 |
| 45 | FGFR4 | 1.16132759 |
| 46 | MARK3 | 1.16036784 |
| 47 | HCK | 1.13617742 |
| 48 | TAOK3 | 1.11488257 |
| 49 | LIMK1 | 1.08986713 |
| 50 | ARAF | 1.06090925 |
| 51 | TEC | 1.05097652 |
| 52 | MAP3K11 | 1.04969517 |
| 53 | BCKDK | 1.04740522 |
| 54 | RIPK1 | 1.03691792 |
| 55 | ALK | 1.00834646 |
| 56 | SIK3 | 1.00760376 |
| 57 | PIM1 | 0.99115266 |
| 58 | TESK1 | 0.98191215 |
| 59 | BMX | 0.94658333 |
| 60 | MYLK | 0.94179658 |
| 61 | RPS6KB2 | 0.93548425 |
| 62 | TAOK2 | 0.93305009 |
| 63 | RIPK4 | 0.91238790 |
| 64 | FLT3 | 0.89347009 |
| 65 | NEK2 | 0.88726316 |
| 66 | JAK2 | 0.88612248 |
| 67 | MAP3K8 | 0.87154609 |
| 68 | MAPKAPK3 | 0.86689742 |
| 69 | IKBKB | 0.85100500 |
| 70 | LCK | 0.85058632 |
| 71 | MATK | 0.84601801 |
| 72 | MAP3K14 | 0.83922389 |
| 73 | LYN | 0.81800298 |
| 74 | IRAK4 | 0.80784927 |
| 75 | ILK | 0.77984223 |
| 76 | FGFR3 | 0.75686869 |
| 77 | ABL2 | 0.74672869 |
| 78 | TLK1 | 0.71835184 |
| 79 | EIF2AK3 | 0.70535638 |
| 80 | PRKCQ | 0.70319292 |
| 81 | KSR2 | 0.68632149 |
| 82 | TGFBR1 | 0.68269982 |
| 83 | TAOK1 | 0.66939856 |
| 84 | NEK1 | 0.65306540 |
| 85 | VRK1 | 0.63968376 |
| 86 | CDK4 | 0.63107453 |
| 87 | PDK2 | 0.62817160 |
| 88 | CAMKK1 | 0.62477549 |
| 89 | MAP3K12 | 0.62257143 |
| 90 | MAPK11 | 0.60509288 |
| 91 | MAP3K3 | 0.59328365 |
| 92 | MAP3K13 | 0.57870920 |
| 93 | CDK6 | 0.56529833 |
| 94 | RET | 0.54905433 |
| 95 | IRAK3 | 0.54404631 |
| 96 | PRKCH | 0.54013850 |
| 97 | MAP3K5 | 0.52626434 |
| 98 | PRPF4B | 0.51218921 |
| 99 | FGR | 0.51015247 |
| 100 | NEK9 | 0.50958001 |
| 101 | PIK3CG | 0.50952919 |
| 102 | PRKCD | 0.49248389 |
| 103 | PRKG2 | 0.46648967 |
| 104 | FYN | 0.44808767 |
| 105 | ACVR1B | 0.44024374 |
| 106 | PAK1 | 0.42693373 |
| 107 | RPS6KA6 | 0.42223433 |
| 108 | CAMK1D | 0.41855113 |
| 109 | EPHA2 | 0.41011995 |
| 110 | PASK | 0.40624060 |
| 111 | CHUK | 0.40173265 |
| 112 | ADRBK2 | 0.38287444 |
| 113 | MOS | 0.38205745 |
| 114 | MAP3K1 | 0.38064835 |
| 115 | PDK1 | 0.37945933 |
| 116 | MAPKAPK2 | 0.37822265 |
| 117 | ABL1 | 0.37628472 |
| 118 | MAPK4 | 0.37462273 |
| 119 | CAMKK2 | 0.36039201 |
| 120 | CLK1 | 0.36006986 |
| 121 | EGFR | 0.35901686 |
| 122 | RPS6KC1 | 0.35838298 |
| 123 | RPS6KL1 | 0.35838298 |
| 124 | DAPK3 | 0.33814411 |
| 125 | EIF2AK1 | 0.33550068 |
| 126 | MAP3K2 | 0.32807058 |
| 127 | SRPK1 | 0.31808977 |
| 128 | DAPK1 | 0.30590368 |
| 129 | TNK2 | 0.30522727 |
| 130 | CSNK2A1 | 0.30108714 |
| 131 | CDK12 | 0.30016980 |
| 132 | CSNK2A2 | 0.30016016 |
| 133 | IRAK1 | 0.28546423 |
| 134 | PRKCI | 0.25132520 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.18065131 |
| 2 | Proteasome_Homo sapiens_hsa03050 | 3.03295227 |
| 3 | Leishmaniasis_Homo sapiens_hsa05140 | 2.85499270 |
| 4 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.83208182 |
| 5 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.56513350 |
| 6 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.49468303 |
| 7 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.41861034 |
| 8 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.39723748 |
| 9 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.39256323 |
| 10 | Parkinsons disease_Homo sapiens_hsa05012 | 2.25557592 |
| 11 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.07874237 |
| 12 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.98406954 |
| 13 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.96067721 |
| 14 | * Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.86347086 |
| 15 | Tuberculosis_Homo sapiens_hsa05152 | 1.83669084 |
| 16 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.83464570 |
| 17 | Measles_Homo sapiens_hsa05162 | 1.81481602 |
| 18 | Legionellosis_Homo sapiens_hsa05134 | 1.77805860 |
| 19 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.76714641 |
| 20 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.75066199 |
| 21 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.74078690 |
| 22 | Pertussis_Homo sapiens_hsa05133 | 1.73696113 |
| 23 | Protein export_Homo sapiens_hsa03060 | 1.73342909 |
| 24 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.69796199 |
| 25 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.69559012 |
| 26 | Lysosome_Homo sapiens_hsa04142 | 1.62680362 |
| 27 | Apoptosis_Homo sapiens_hsa04210 | 1.60543438 |
| 28 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.55817874 |
| 29 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.55794466 |
| 30 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.55722445 |
| 31 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.53591924 |
| 32 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.50735610 |
| 33 | Alzheimers disease_Homo sapiens_hsa05010 | 1.49407500 |
| 34 | Other glycan degradation_Homo sapiens_hsa00511 | 1.44548842 |
| 35 | * Shigellosis_Homo sapiens_hsa05131 | 1.43953113 |
| 36 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.43339527 |
| 37 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.42533598 |
| 38 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.39152226 |
| 39 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.37767430 |
| 40 | Hepatitis B_Homo sapiens_hsa05161 | 1.36416111 |
| 41 | Huntingtons disease_Homo sapiens_hsa05016 | 1.35525650 |
| 42 | * Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.35102085 |
| 43 | Ribosome_Homo sapiens_hsa03010 | 1.30809604 |
| 44 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.27366171 |
| 45 | Influenza A_Homo sapiens_hsa05164 | 1.27177676 |
| 46 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.25886872 |
| 47 | Malaria_Homo sapiens_hsa05144 | 1.25568851 |
| 48 | DNA replication_Homo sapiens_hsa03030 | 1.25244911 |
| 49 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.24956254 |
| 50 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.24563072 |
| 51 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.21254615 |
| 52 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.19804070 |
| 53 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.18697644 |
| 54 | Viral myocarditis_Homo sapiens_hsa05416 | 1.16636160 |
| 55 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.15140365 |
| 56 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.14409328 |
| 57 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.13447056 |
| 58 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.11292043 |
| 59 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.10818371 |
| 60 | Platelet activation_Homo sapiens_hsa04611 | 1.09789560 |
| 61 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.08240889 |
| 62 | * Salmonella infection_Homo sapiens_hsa05132 | 1.06249284 |
| 63 | * Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.06170879 |
| 64 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.02484884 |
| 65 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.00012455 |
| 66 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.96881869 |
| 67 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.95835204 |
| 68 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.91635128 |
| 69 | Allograft rejection_Homo sapiens_hsa05330 | 0.86231242 |
| 70 | Phagosome_Homo sapiens_hsa04145 | 0.85807023 |
| 71 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.85754241 |
| 72 | Amoebiasis_Homo sapiens_hsa05146 | 0.85468415 |
| 73 | Asthma_Homo sapiens_hsa05310 | 0.83179505 |
| 74 | Hepatitis C_Homo sapiens_hsa05160 | 0.82776629 |
| 75 | HTLV-I infection_Homo sapiens_hsa05166 | 0.82018087 |
| 76 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.81487575 |
| 77 | Colorectal cancer_Homo sapiens_hsa05210 | 0.79870926 |
| 78 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.79628716 |
| 79 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.78464405 |
| 80 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.71941676 |
| 81 | RNA polymerase_Homo sapiens_hsa03020 | 0.71061800 |
| 82 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.69353531 |
| 83 | * Endocytosis_Homo sapiens_hsa04144 | 0.69214793 |
| 84 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.68339797 |
| 85 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.67490752 |
| 86 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.67366746 |
| 87 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.66064950 |
| 88 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.64482900 |
| 89 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.63877319 |
| 90 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.62980974 |
| 91 | Insulin resistance_Homo sapiens_hsa04931 | 0.62090705 |
| 92 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.61269115 |
| 93 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.60419882 |
| 94 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.59788758 |
| 95 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.59096744 |
| 96 | Bladder cancer_Homo sapiens_hsa05219 | 0.58285428 |
| 97 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.58253695 |
| 98 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.55670934 |
| 99 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.55610008 |
| 100 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.54848902 |
| 101 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.54772356 |
| 102 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.52811726 |
| 103 | Base excision repair_Homo sapiens_hsa03410 | 0.52341934 |
| 104 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.51788349 |
| 105 | Glioma_Homo sapiens_hsa05214 | 0.51755003 |
| 106 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.51407085 |
| 107 | Spliceosome_Homo sapiens_hsa03040 | 0.51366509 |
| 108 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.50101185 |
| 109 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.49661998 |
| 110 | Focal adhesion_Homo sapiens_hsa04510 | 0.48621891 |
| 111 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.47513953 |
| 112 | * Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.47092909 |
| 113 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.46721757 |
| 114 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.46447792 |
| 115 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.44685720 |
| 116 | Thyroid cancer_Homo sapiens_hsa05216 | 0.42938738 |
| 117 | Endometrial cancer_Homo sapiens_hsa05213 | 0.42563215 |
| 118 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.42426160 |
| 119 | Sulfur relay system_Homo sapiens_hsa04122 | 0.41591565 |
| 120 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.40405014 |
| 121 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.40383278 |
| 122 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.40299462 |
| 123 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.40071435 |
| 124 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.38730381 |
| 125 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.36956662 |
| 126 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.36627083 |
| 127 | Galactose metabolism_Homo sapiens_hsa00052 | 0.34849499 |
| 128 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.32004335 |
| 129 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.31742293 |
| 130 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.30916806 |
| 131 | Homologous recombination_Homo sapiens_hsa03440 | 0.28972645 |
| 132 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.27683286 |
| 133 | Mismatch repair_Homo sapiens_hsa03430 | 0.24585857 |
| 134 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.24547239 |
| 135 | Mineral absorption_Homo sapiens_hsa04978 | 0.21666436 |
| 136 | Peroxisome_Homo sapiens_hsa04146 | 0.20550601 |
| 137 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.19832911 |
| 138 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.19336135 |

